【摘要】：目的探討介入溶栓治療腦梗死的臨床療效,為腦梗死臨床治療提供理論依據(jù)。方法選取2013年2月—2016年2月在我院接受治療的腦梗死患者92例,隨機(jī)分為觀察組和對(duì)照組,每組各46例。對(duì)照組患者采用靜脈溶栓進(jìn)行治療,觀察組患者采用介入溶栓進(jìn)行治療,分析比較兩組患者不同時(shí)間段歐洲腦卒中量表(ESS)評(píng)分以及治療后血管再通情況。結(jié)果觀察組治療后1周、2周、4周ESS評(píng)分高于對(duì)照組(P0.05)。觀察組血管完全再通率、部分再通率均高于對(duì)照組(P0.05);觀察組血管未通率低于對(duì)照組(P0.05)。結(jié)論介入溶栓治療腦梗死臨床療效顯著,可有效改善神經(jīng)功能,提高患者生活質(zhì)量,值得臨床推廣應(yīng)用。
[Abstract]:Objective to explore the clinical effect of interventional thrombolytic therapy on cerebral infarction and provide theoretical basis for clinical treatment of cerebral infarction. Methods 92 patients with cerebral infarction who were treated in our hospital from February 2013 to February 2016 were randomly divided into observation group (n = 46) and control group (n = 46). The patients in the control group were treated with intravenous thrombolytic therapy, and the patients in the observation group were treated with interventional thrombolytic therapy. The (ESS) score of European Stroke scale and the vascular recanalization after treatment were analyzed and compared between the two groups. Results the ESS score in the observation group was higher than that in the control group at 1 week, 2 weeks and 4 weeks after treatment (P0.05). The complete recanalization rate and partial recanalization rate in the observation group were higher than those in the control group (P0.05), while the non-patency rate in the observation group was lower than that in the control group (P0.05). Conclusion Interventional thrombolytic therapy is effective in the treatment of cerebral infarction, which can effectively improve the neurological function and improve the quality of life of the patients.
【作者單位】： 余干信江醫(yī)院神經(jīng)內(nèi)科;
【分類號(hào)】：R743.33

【相似文獻(xiàn)】

相關(guān)期刊論文 前1條

1 許國(guó)凡;;關(guān)于臨床療效研究中的對(duì)照問(wèn)題[J];中國(guó)衛(wèi)生統(tǒng)計(jì);1987年01期

，

本文編號(hào)：2314461